Mirum Pharmaceuticals, Inc.
MIRMNASDAQHealthcare● Active
$93.59
+$0.11(+0.11%)
Market Cap$4.7B
P/E Ratio—
52W High$114.99
52W Low$47.15
Mirum Pharmaceuticals, Inc.（MIRM）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · MIRM · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.38B | $0.28B | $0.29B | $0.15B | $0.16B |
| Net Receivables | $0.12B | $0.08B | $0.07B | $0.02B | $0.00B |
| Inventory | $0.02B | $0.02B | $0.02B | $0.01B | $0.00B |
| Total Current Assets | $0.55B | $0.39B | $0.39B | $0.19B | $0.17B |
| PP&E Net | $0.00B | $0.01B | $0.00B | $0.00B | $0.00B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.26B | $0.25B | $0.25B | $0.06B | $0.02B |
| Total Assets | $0.84B | $0.67B | $0.65B | $0.35B | $0.29B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Total Current Liabilities | $0.21B | $0.13B | $0.09B | $0.06B | $0.04B |
| Long-Term Debt | $0.31B | $0.31B | $0.31B | $0.00B | $0.00B |
| Total Liabilities | $0.53B | $0.45B | $0.40B | $0.21B | $0.17B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.67B) | ($0.64B) | ($0.56B) | ($0.39B) | ($0.26B) |
| Total Stockholders Equity | $0.31B | $0.23B | $0.25B | $0.14B | $0.12B |
| Total Liab & Equity(computed) | $0.84B | $0.67B | $0.65B | $0.35B | $0.29B |
| Debt Summary | |||||
| Total Debt | $0.32B | $0.32B | $0.31B | $0.00B | $0.00B |
| Net Debt | $0.02B | $0.10B | $0.02B | ($0.03B) | ($0.03B) |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Mirum Pharmaceuticals, Inc.
关于Mirum Pharmaceuticals, Inc.（MIRM）资产负债表
Mirum Pharmaceuticals, Inc.总资产$0.84B，现金及短期投资$0.38B，总负债$0.53B，总债务$0.32B，股东权益$0.31B。
常见问题
MIRM · 4 问Mirum Pharmaceuticals, Inc.总债务$0.32B，净债务$0.02B。
MIRM total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10